BIOLOGICAL · Unmapped registry intervention
GVAX prostate cancer vaccine
Find medicine records ·
Find other trials using this name
Clinical trial
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
NCT00771017
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
bicalutamide
Normalized identity: bicalutamideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
goserelin
Normalized identity: goserelinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
leuprolide acetate
Normalized identity: leuprolide acetateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAndrogen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
GVAX prostate cancer vaccineBIOLOGICAL
bicalutamideDRUG · verified · RxNorm: bicalutamide
goserelinDRUG · verified · RxNorm: goserelin
leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate
Sponsors & collaborators
Eastern Cooperative Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00771017 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.